US Stock MarketDetailed Quotes

XERS Xeris Pharmaceuticals

Watchlist
  • 3.540
  • -0.070-1.94%
Close Jan 6 16:00 ET
  • 3.550
  • +0.010+0.28%
Post 19:24 ET
527.75MMarket Cap-8.23P/E (TTM)

Xeris Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
12.31%54.27M
26.46%48.07M
22.42%40.64M
48.68%163.91M
33.93%44.39M
62.56%48.32M
50.19%38.01M
50.39%33.2M
122.32%110.25M
54.67%33.14M
Operating revenue
12.31%54.27M
26.46%48.07M
22.42%40.64M
48.68%163.91M
33.93%44.39M
62.56%48.32M
50.19%38.01M
50.39%33.2M
122.32%110.25M
54.67%33.14M
Cost of revenue
65.75%13.59M
3.11%7.79M
12.26%5.97M
26.56%28.65M
20.33%7.57M
55.91%8.2M
57.07%7.56M
-15.21%5.32M
69.95%22.63M
28.68%6.29M
Gross profit
1.39%40.68M
32.25%40.28M
24.36%34.67M
54.39%135.27M
37.12%36.82M
63.99%40.12M
48.58%30.45M
76.44%27.88M
141.55%87.61M
62.35%26.85M
Operating expense
18.96%53.57M
4.37%48.46M
18.85%48.91M
5.74%179.28M
11.04%46.66M
4.13%45.03M
17.81%46.43M
-8.29%41.15M
11.97%169.55M
-35.16%42.02M
Selling and administrative expenses
20.60%44.97M
6.27%39.99M
14.21%38.38M
6.06%146.1M
9.35%37.57M
8.11%37.29M
14.10%37.64M
-6.43%33.61M
9.57%137.75M
-36.59%34.36M
Research and development costs
16.96%5.89M
-5.39%5.76M
61.66%7.82M
6.56%22.34M
28.80%6.38M
-16.70%5.03M
63.72%6.09M
-22.59%4.84M
-16.67%20.97M
-50.85%4.96M
Depreciation amortization depletion
0.00%2.71M
0.00%2.71M
0.00%2.71M
0.00%10.84M
0.00%2.71M
0.00%2.71M
0.00%2.71M
0.00%2.71M
1,871.45%10.84M
392.91%2.71M
-Depreciation and amortization
0.00%2.71M
0.00%2.71M
0.00%2.71M
0.00%10.84M
0.00%2.71M
0.00%2.71M
0.00%2.71M
0.00%2.71M
1,871.45%10.84M
392.91%2.71M
Operating profit
-162.43%-12.89M
48.76%-8.19M
-7.29%-14.25M
46.29%-44.01M
35.13%-9.84M
73.84%-4.91M
15.53%-15.98M
54.33%-13.28M
28.84%-81.94M
68.57%-15.17M
Net non-operating interest income expense
-15.07%-6.59M
-25.79%-6.67M
-58.65%-7.8M
-89.67%-21.86M
-134.19%-5.91M
-62.81%-5.73M
-63.08%-5.31M
-42.37%-4.92M
-67.82%-11.52M
-46.23%-2.52M
Non-operating interest income
6.78%1.2M
5.56%1.29M
47.92%1.92M
84.29%4.75M
-39.93%1.11M
137.50%1.12M
527.18%1.22M
1,811.76%1.3M
723.64%2.58M
2,532.86%1.84M
Non-operating interest expense
13.71%7.79M
22.00%7.96M
13.13%7.03M
88.69%26.61M
60.71%7.02M
71.65%6.85M
89.33%6.53M
76.54%6.22M
96.41%14.1M
143.15%4.37M
Total other finance cost
----
----
--2.69M
----
----
----
----
----
----
----
Other net income (expense)
122.25%420K
-21.25%604K
148.05%3.37M
190.23%2.36M
-51.97%2.13M
-1,586.61%-1.89M
117.61%767K
185.20%1.36M
-273.22%-2.62M
658.13%4.43M
Gain on sale of security
----
121.43%3K
--4K
-99.94%1K
-114.29%-2K
88.89%17K
-102.71%-14K
----
350.71%1.76M
101.77%14K
Special income (charges)
122.05%420K
-23.05%601K
147.76%3.37M
153.95%2.36M
-51.77%2.13M
-1,714.41%-1.91M
116.03%781K
148.26%1.36M
---4.38M
--4.41M
-Less:Restructuring and merger&acquisition
54.94%-420K
23.05%-601K
-147.76%-3.37M
-264.71%-5.2M
51.77%-2.13M
-689.83%-932K
-116.03%-781K
-148.26%-1.36M
--3.16M
---4.41M
-Less:Other special charges
----
----
----
131.97%2.84M
--0
--2.84M
----
----
--1.22M
--0
Income before tax
-52.17%-19.06M
30.52%-14.26M
-10.92%-18.67M
33.91%-63.5M
-2.70%-13.63M
43.50%-12.53M
22.65%-20.52M
50.67%-16.83M
21.71%-96.08M
73.88%-13.27M
Income tax
-883.43%-3.32M
210.96%749K
307K
12.29%-1.25M
30.18%-236K
0.29%-338K
-99.12%-675K
0
-1.42M
-338K
Net income
-29.12%-15.74M
24.38%-15.01M
-12.75%-18.98M
34.23%-62.26M
-3.56%-13.39M
44.17%-12.19M
24.22%-19.84M
50.07%-16.83M
22.87%-94.66M
74.54%-12.93M
Net income continuous Operations
-29.12%-15.74M
24.38%-15.01M
-12.75%-18.98M
34.23%-62.26M
-3.56%-13.39M
44.17%-12.19M
24.22%-19.84M
50.07%-16.83M
22.87%-94.66M
74.54%-12.93M
Minority interest income
Net income attributable to the parent company
-29.12%-15.74M
24.38%-15.01M
-12.75%-18.98M
34.23%-62.26M
-3.56%-13.39M
44.17%-12.19M
24.22%-19.84M
50.07%-16.83M
22.87%-94.66M
74.54%-12.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-29.12%-15.74M
24.38%-15.01M
-12.75%-18.98M
34.23%-62.26M
-3.56%-13.39M
44.17%-12.19M
24.22%-19.84M
50.07%-16.83M
22.87%-94.66M
74.54%-12.93M
Basic earnings per share
-22.22%-0.11
28.57%-0.1
-16.67%-0.14
35.71%-0.45
10.00%-0.09
43.75%-0.09
26.32%-0.14
52.00%-0.12
54.84%-0.7
76.19%-0.1
Diluted earnings per share
-22.22%-0.11
28.57%-0.1
-16.67%-0.14
35.71%-0.45
10.00%-0.09
43.75%-0.09
26.32%-0.14
52.00%-0.12
54.84%-0.7
76.19%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 12.31%54.27M26.46%48.07M22.42%40.64M48.68%163.91M33.93%44.39M62.56%48.32M50.19%38.01M50.39%33.2M122.32%110.25M54.67%33.14M
Operating revenue 12.31%54.27M26.46%48.07M22.42%40.64M48.68%163.91M33.93%44.39M62.56%48.32M50.19%38.01M50.39%33.2M122.32%110.25M54.67%33.14M
Cost of revenue 65.75%13.59M3.11%7.79M12.26%5.97M26.56%28.65M20.33%7.57M55.91%8.2M57.07%7.56M-15.21%5.32M69.95%22.63M28.68%6.29M
Gross profit 1.39%40.68M32.25%40.28M24.36%34.67M54.39%135.27M37.12%36.82M63.99%40.12M48.58%30.45M76.44%27.88M141.55%87.61M62.35%26.85M
Operating expense 18.96%53.57M4.37%48.46M18.85%48.91M5.74%179.28M11.04%46.66M4.13%45.03M17.81%46.43M-8.29%41.15M11.97%169.55M-35.16%42.02M
Selling and administrative expenses 20.60%44.97M6.27%39.99M14.21%38.38M6.06%146.1M9.35%37.57M8.11%37.29M14.10%37.64M-6.43%33.61M9.57%137.75M-36.59%34.36M
Research and development costs 16.96%5.89M-5.39%5.76M61.66%7.82M6.56%22.34M28.80%6.38M-16.70%5.03M63.72%6.09M-22.59%4.84M-16.67%20.97M-50.85%4.96M
Depreciation amortization depletion 0.00%2.71M0.00%2.71M0.00%2.71M0.00%10.84M0.00%2.71M0.00%2.71M0.00%2.71M0.00%2.71M1,871.45%10.84M392.91%2.71M
-Depreciation and amortization 0.00%2.71M0.00%2.71M0.00%2.71M0.00%10.84M0.00%2.71M0.00%2.71M0.00%2.71M0.00%2.71M1,871.45%10.84M392.91%2.71M
Operating profit -162.43%-12.89M48.76%-8.19M-7.29%-14.25M46.29%-44.01M35.13%-9.84M73.84%-4.91M15.53%-15.98M54.33%-13.28M28.84%-81.94M68.57%-15.17M
Net non-operating interest income expense -15.07%-6.59M-25.79%-6.67M-58.65%-7.8M-89.67%-21.86M-134.19%-5.91M-62.81%-5.73M-63.08%-5.31M-42.37%-4.92M-67.82%-11.52M-46.23%-2.52M
Non-operating interest income 6.78%1.2M5.56%1.29M47.92%1.92M84.29%4.75M-39.93%1.11M137.50%1.12M527.18%1.22M1,811.76%1.3M723.64%2.58M2,532.86%1.84M
Non-operating interest expense 13.71%7.79M22.00%7.96M13.13%7.03M88.69%26.61M60.71%7.02M71.65%6.85M89.33%6.53M76.54%6.22M96.41%14.1M143.15%4.37M
Total other finance cost ----------2.69M----------------------------
Other net income (expense) 122.25%420K-21.25%604K148.05%3.37M190.23%2.36M-51.97%2.13M-1,586.61%-1.89M117.61%767K185.20%1.36M-273.22%-2.62M658.13%4.43M
Gain on sale of security ----121.43%3K--4K-99.94%1K-114.29%-2K88.89%17K-102.71%-14K----350.71%1.76M101.77%14K
Special income (charges) 122.05%420K-23.05%601K147.76%3.37M153.95%2.36M-51.77%2.13M-1,714.41%-1.91M116.03%781K148.26%1.36M---4.38M--4.41M
-Less:Restructuring and merger&acquisition 54.94%-420K23.05%-601K-147.76%-3.37M-264.71%-5.2M51.77%-2.13M-689.83%-932K-116.03%-781K-148.26%-1.36M--3.16M---4.41M
-Less:Other special charges ------------131.97%2.84M--0--2.84M----------1.22M--0
Income before tax -52.17%-19.06M30.52%-14.26M-10.92%-18.67M33.91%-63.5M-2.70%-13.63M43.50%-12.53M22.65%-20.52M50.67%-16.83M21.71%-96.08M73.88%-13.27M
Income tax -883.43%-3.32M210.96%749K307K12.29%-1.25M30.18%-236K0.29%-338K-99.12%-675K0-1.42M-338K
Net income -29.12%-15.74M24.38%-15.01M-12.75%-18.98M34.23%-62.26M-3.56%-13.39M44.17%-12.19M24.22%-19.84M50.07%-16.83M22.87%-94.66M74.54%-12.93M
Net income continuous Operations -29.12%-15.74M24.38%-15.01M-12.75%-18.98M34.23%-62.26M-3.56%-13.39M44.17%-12.19M24.22%-19.84M50.07%-16.83M22.87%-94.66M74.54%-12.93M
Minority interest income
Net income attributable to the parent company -29.12%-15.74M24.38%-15.01M-12.75%-18.98M34.23%-62.26M-3.56%-13.39M44.17%-12.19M24.22%-19.84M50.07%-16.83M22.87%-94.66M74.54%-12.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -29.12%-15.74M24.38%-15.01M-12.75%-18.98M34.23%-62.26M-3.56%-13.39M44.17%-12.19M24.22%-19.84M50.07%-16.83M22.87%-94.66M74.54%-12.93M
Basic earnings per share -22.22%-0.1128.57%-0.1-16.67%-0.1435.71%-0.4510.00%-0.0943.75%-0.0926.32%-0.1452.00%-0.1254.84%-0.776.19%-0.1
Diluted earnings per share -22.22%-0.1128.57%-0.1-16.67%-0.1435.71%-0.4510.00%-0.0943.75%-0.0926.32%-0.1452.00%-0.1254.84%-0.776.19%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data